ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 164 filers reported holding ACCELERON PHARMA INC in Q4 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $71,990,000 | +388.5% | 418,302 | +256.2% | 0.02% | +400.0% |
| Q2 2021 | $14,736,000 | -75.9% | 117,424 | -73.9% | 0.00% | -80.0% |
| Q1 2021 | $61,043,000 | +44.4% | 450,137 | +36.2% | 0.02% | +50.0% |
| Q4 2020 | $42,274,000 | -21.9% | 330,427 | -31.3% | 0.01% | -33.3% |
| Q3 2020 | $54,098,000 | +15.2% | 480,742 | -2.5% | 0.02% | +7.1% |
| Q2 2020 | $46,969,000 | -4.7% | 493,011 | -10.1% | 0.01% | -22.2% |
| Q1 2020 | $49,273,000 | +163.0% | 548,270 | +55.2% | 0.02% | +350.0% |
| Q4 2019 | $18,733,000 | +19.6% | 353,305 | -10.9% | 0.00% | -20.0% |
| Q3 2019 | $15,667,000 | -11.4% | 396,542 | -7.9% | 0.01% | 0.0% |
| Q2 2019 | $17,681,000 | -17.6% | 430,409 | -6.6% | 0.01% | -16.7% |
| Q1 2019 | $21,466,000 | +91.7% | 460,941 | +79.3% | 0.01% | +50.0% |
| Q4 2018 | $11,199,000 | -57.5% | 257,142 | -44.1% | 0.00% | -42.9% |
| Q3 2018 | $26,326,000 | +0.3% | 460,011 | -15.0% | 0.01% | 0.0% |
| Q2 2018 | $26,243,000 | +20.9% | 540,880 | -2.5% | 0.01% | +16.7% |
| Q1 2018 | $21,701,000 | -21.3% | 555,019 | -14.6% | 0.01% | 0.0% |
| Q4 2017 | $27,586,000 | +16.8% | 649,981 | +2.7% | 0.01% | 0.0% |
| Q3 2017 | $23,612,000 | +49.4% | 632,681 | +21.7% | 0.01% | +50.0% |
| Q2 2017 | $15,804,000 | +18.6% | 520,057 | +3.3% | 0.00% | 0.0% |
| Q1 2017 | $13,326,000 | +10.2% | 503,439 | +6.3% | 0.00% | +33.3% |
| Q4 2016 | $12,091,000 | -60.6% | 473,805 | -44.1% | 0.00% | -66.7% |
| Q3 2016 | $30,664,000 | +74.6% | 847,283 | +63.9% | 0.01% | +50.0% |
| Q2 2016 | $17,563,000 | +45.5% | 516,874 | +13.0% | 0.01% | +50.0% |
| Q1 2016 | $12,069,000 | -21.8% | 457,327 | +44.5% | 0.00% | 0.0% |
| Q4 2015 | $15,427,000 | +6196.7% | 316,381 | +3116.6% | 0.00% | – |
| Q3 2015 | $245,000 | -94.0% | 9,836 | -92.4% | 0.00% | – |
| Q2 2015 | $4,070,000 | +850.9% | 128,640 | +1043.3% | 0.00% | – |
| Q1 2015 | $428,000 | -33.0% | 11,252 | -31.4% | 0.00% | – |
| Q4 2014 | $639,000 | – | 16,399 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
| Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
| GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
| Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
| Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
| Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
| QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
| Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
| Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |